AI Market Mood: Stock Dashboard
TFX
Fundamental
Company: Teleflex Incorporated
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: USA
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -7.36
Insider Own: 0.73%
Shs Outstand: 44.19M
Perf Week: 3.40%
Market Cap: 4.89B
Forward P/E: 7.27
EPS next Y: 15.22
Insider Trans: 1.73%
Shs Float: 43.87M
Perf Month: -16.40%
Enterprise Value: 7.29B
PEG: -
EPS next Q: 3.84
Inst Own: 106.17%
Short Float: 4.19%
Perf Quarter: -13.26%
Income: -327.97M
P/S: 1.53
EPS this Y: 0.63%
Inst Trans: -1.75%
Short Ratio: 3.04
Perf Half Y: -8.40%
Sales: 3.19B
P/B: 1.28
EPS next Y Percentage: 7.98%
ROA: -4.27%
Short Interest: 1.84M
Perf YTD: -37.84%
Book/sh: 86.48
P/C: 13.26
EPS next 5Y: 5.76%
ROE: -7.90%
52W High: 195.42 -43.38%
Perf Year: -42.69%
Cash/sh: 8.34
P/FCF: 18.50
EPS past 3/5Y: -47.52% -31.49%
ROIC: -5.05%
52W Low: 102.58 7.86%
Perf 3Y: -49.08%
Dividend Est.: 1.35 (1.22%)
EV/EBITDA: 8.57
Sales past 3/5Y: 2.74% 3.26%
Gross Margin: 53.86%
Volatility W: 3.72%
Volatility M: 3.66%
Perf 5Y: -70.51%
Dividend TTM: 1.36 (1.23%)
EV/Sales: 2.29
EPS Y/Y TTM: -245.18%
Oper. Margin: 17.79%
ATR (14): 4.42
Perf 10Y: -13.89%
Dividend Ex-Date: Nov 14, 2025
Quick Ratio: 1.53
Sales Y/Y TTM: 5.43%
Profit Margin: -10.28%
RSI (14): 43.01
Recom: 2.92
Dividend Gr. 3/5Y: 0.00% 0.00%
Current Ratio: 2.57
EPS Q/Q: -491.46%
SMA20: -4.25%
Beta: 0.99
Target Price: 125.50
Payout: 91.92%
Debt/Eq: 0.72
Sales Q/Q: 19.45%
SMA50: -8.85%
Rel Volume: 0.43
Prev Close: 104.64
Employees: 14100
LT Debt/Eq: 0.70
Earnings: Nov 06 BMO
SMA200: -13.53%
Avg Volume: 604.54K
Price: 110.64
IPO: Apr 24, 1967
Option/Short: Yes / Yes
EPS/Sales Surpr.: 7.63% 0.01%
Trades:
Volume: 116,275
Change: 5.73%
Technical:
Latest News:
Wells Fargo Sticks to Its Hold Rating for Teleflex (TFX) | Markets Insider neutral
TFX TFX
Summary: Analysts from Wells Fargo, Needham, and JMP Securities recently provided ratings on Teleflex (TFX) with varying perspectives. Teleflex reported a quarterly revenue of $773.91 million, slightly higher than the previous year, but with a lower net profit. The company provides medical technology products focused on improving patient outcomes and safety.
Full article2024-05-03T18:12:46Z